Michael J. Hanley

Michael J. Hanley (born December 9, 1955) is the current chairman of the Saginaw County Board of Commissioners and a former Democratic member of the Michigan House of Representatives.

Born in December 1955 in Saginaw, Hanley graduated from Arthur Hill High School in 1974. He received a degree in political science from Western Michigan University, graduating summa cum laude. Hanley worked for 17 years for General Motors' Saginaw Division. He was elected to Saginaw City Council in 1987 and was re-elected in 1991; he served as mayor ''pro tempore'' from 1991 to 1993. In 1994, Hanley was elected to the Michigan House of Representatives. Re-elected twice, he served as Democratic leader from 1999 to 2000.

Hanley was or is involved in numerous community organizations, including as a past chair of the Mayor's Housing Task Force, treasurer of the Solid Waste Management Authority, the East Central Michigan Planning and Development Region Board, and the Underground Railroad Shelter for Battered Women and Children.

Hanley was elected to the Saginaw County Board of Commissioners in 2008, and became chairman of the board in 2013. Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'Michael J. Hanley', query time: 0.03s Refine Results
  1. 1
    Mobocertinib: Mechanism of action, clinical, and translational science

    Mobocertinib: Mechanism of action, clinical, and translational science by Michael J. Hanley, D. Ross Camidge, Robert J. Fram, Neeraj Gupta

    Published 2024-03-01
    Get full text
    Article
  2. 2
    Population pharmacokinetics of mobocertinib in healthy volunteers and patients with non–small cell lung cancer

    Population pharmacokinetics of mobocertinib in healthy volunteers and patients with non–small cell lung cancer by Neeraj Gupta, Philippe B. Pierrillas, Michael J. Hanley, Steven Zhang, Paul M. Diderichsen

    Published 2022-06-01
    Get full text
    Article
  3. 3
    Population pharmacokinetic/pharmacodynamic joint modeling of ixazomib efficacy and safety using data from the pivotal phase III TOURMALINE‐MM1 study in multiple myeloma patients

    Population pharmacokinetic/pharmacodynamic joint modeling of ixazomib efficacy and safety using data from the pivotal phase III TOURMALINE‐MM1 study in multiple myeloma patients by Jaydeep K. Srimani, Paul M. Diderichsen, Michael J. Hanley, Karthik Venkatakrishnan, Richard Labotka, Neeraj Gupta

    Published 2022-08-01
    Get full text
    Article
  4. 4
    Evaluation of the drug–drug interaction potential of brigatinib using a physiologically‐based pharmacokinetic modeling approach

    Evaluation of the drug–drug interaction potential of brigatinib using a physiologically‐based pharmacokinetic modeling approach by Michael J. Hanley, Karen Rowland Yeo, Meera Tugnait, Shinji Iwasaki, Narayana Narasimhan, Pingkuan Zhang, Karthik Venkatakrishnan, Neeraj Gupta

    Published 2024-04-01
    Get full text
    Article
  5. 5
    Population pharmacokinetic and exposure‐response analyses from ALTA‐1L: Model‐based analyses supporting the brigatinib dose in ALK‐positive NSCLC

    Population pharmacokinetic and exposure‐response analyses from ALTA‐1L: Model‐based analyses supporting the brigatinib dose in ALK‐positive NSCLC by Neeraj Gupta, Karen L. Reckamp, David R. Camidge, Huub J. Kleijn, Aziz Ouerdani, Francesco Bellanti, John Maringwa, Michael J. Hanley, Shining Wang, Pingkuan Zhang, Karthik Venkatakrishnan

    Published 2022-05-01
    Get full text
    Article
  6. 6
    Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study

    Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation s... by Jian Hou, Jie Jin, Yan Xu, Depei Wu, Xiaoyan Ke, Daobin Zhou, Jin Lu, Xin Du, Xiequn Chen, Junmin Li, Jing Liu, Neeraj Gupta, Michael J. Hanley, Hongmei Li, Zhaowei Hua, Bingxia Wang, Xiaoquan Zhang, Hui Wang, Helgi van de Velde, Paul G. Richardson, Philippe Moreau

    Published 2017-07-01
    Get full text
    Article

Search Tools: